Friday, August 14, 2026

North Korea Ramps Up Patriotism, Calls for Self-Reliance in Tough Times

North Korea emphasizes self-reliance for economic growth as it prepares for the Workers' Party's 80th anniversary, highlighting discipline and national pride.

Swim, Bike, Run? Not If the Seine Has Its Say: Triathlon’s Uncertain Future

Questions loom about the feasibility of hosting the triathlon events at the Paris 2024 Olympics as planned.

U.S. Beef Tops Korea’s Imported Meat Market for Ninth Straight Year as Tariffs Drop to Zero

American beef leads Korea's meat market with 47.1% share in 2025, supported by strong consumer approval and tariff elimination.

Tag: ST Pharm

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

ST Pharm Expands Global CDMO Outreach at TIDES USA and ASGCT 2026

ST Pharm showcased its CDMO capabilities at TIDES USA and ASGCT 2026, focusing on nucleic acid therapeutics and strategic partnerships.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.